Appearance of Islet Cell Autoantibodies after Clinical Diagnosis of Diabetes Mellitus

References

• Landin-Olsson M., Karlsson F., Lernmark Å., Sundkvist G. and the Diabetes Incidence Study in Sweden Group. Islet cell and thyrogastric antibodies in 633 consequtivc 15 34-yr-old patients in the Diabetes Incidence Study in Sweden. Diabetes 1992; 41: 1022–1027
   PubMed Web of Science ®Google Scholar
• Yanderwalle C. L., Falorni A., Svanholm S., Lernmark A., Pipcleers D. G., Gorus F. K., Registry T. B.D. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J. Clin. Endocrinol. Metab. 1995; 80: 846–851
   PubMed Web of Science ®Google Scholar
• Hagopian W. A., Sanjeevi C. B., Kockum I., Lundin-Olsson M., Karlsen A. E., Sundkvist G., Dahlquist G., Palmer J., Lernmark A. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 1995; 95: 1505–1511
   PubMed Web of Science ®Google Scholar
• Bingley P. J., Bonifacio E., Shattock M., Gillmor H. A., Sawlell P. A., Dunger D. B., Scott R. D.M., Bottazzo G. F., Gale E. A.M. Can islet cell antibodies predict IDDM in the general population?. Diabetes Care 1993; 16: 45–50
   PubMed Web of Science ®Google Scholar
• Bingley P., Bonifacio F., Gale E. A.M. Can we really predict IDDM?. Diabetes 1993; 42: 213–220
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Karlsson A., Dahlquist G., Blom L., Lernmark A., Sundkvist G. Islet cell and other organspecific autoantibodies in all children developing Type I (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387–395
   PubMed Web of Science ®Google Scholar
• Riley W. J., Maclaren N. K., Krischer J., Spillar R. P., Silverstein J. H., Schatz D. A., Schwartz S., Malone J., Shah S., Vadheim C., Roller J. I. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 1990; 323: 1167–1172
   PubMed Web of Science ®Google Scholar
• Castano L., Eisenbarth G. S. Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Ann. Rev. Immunol. 1990; 8: 647–679
   PubMed Web of Science ®Google Scholar
• Birk O. S., Cohen I. R. T-cell autoimmunity in type 1 diabetes meilitus. Curr. Op. Immunol. 1993; 5: 903–909
   PubMed Web of Science ®Google Scholar
• Roeb B. O., Devrics R. R.P. T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes meilitus. Eur. J. Clin. Invest. 1992; 22: 697–711
   PubMed Web of Science ®Google Scholar
• Marner B., Agner T., Binder C., et al. Islet cell antibodies predict loss of fasting C-peptide. Diabetologia 1987; 27: 307A
   Google Scholar
• Gottsäler A., Landin-Olsson M., Fernlund P., Lernmark A., Sundkvist G. Beta-cell function in relation to islet cell antibodies (ICA) during the first three years after the clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 1993; 16: 902–910
   PubMed Web of Science ®Google Scholar
• Falorni A., Grubin C., Takei I., Shimada A., Kasuga A., Maruyama T., Ozawa Y., Kasatani T., Saruta T., Li L. Radioimmunoassay detects the frequent occurence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113–25
   PubMed Web of Science ®Google Scholar
• Sundkvist P., Hagopian W. A., Landin-Olsson M., Lernmark A., Ohlson F., Erocsson C., Ahlmén J. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes meilitus. J. Clin. Endocrinol. Metab. 1994; 78: 1159–1165
   PubMed Web of Science ®Google Scholar
• Marner B., Agner T., Binder C., et al. Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type I (insulin-dependent) diabetic patients. Diabetologia 1985; 28: 875–880
   PubMed Web of Science ®Google Scholar
• Wallensteen M., Dahlquist G., Persson B., Landin-Olsson M., Lernmark A., Sundkvist G., Thalme B. Factors influencing the magnitude, duration, and rate of fall of b-cell function i Type 1 (insulin-dependent) diabetes children followed for two years from their clinical diagnosis. Diabetologia 1988; 31: 664–669
   PubMed Web of Science ®Google Scholar
• Ostman J., Lernmark A., Landin-Olsson M., Sundkvist G., Palmer J., Arnqvist H., Blohme G., Lithner F., Littorin B., Nystrom L., Scherstén B., Wibell L. Autoimmune (Type 1) diabetes in young adults in Sweden. Horm. Metab. Rex. 1996; 28: 348–350
   PubMed Web of Science ®Google Scholar
• WHO Study Group. Diabetes meilitus. WHO Technical Report Series, 1985; 727
   Google Scholar
• Landin-Olsson M., Sundkvist G., Lernmark A. Prolonged incubation on the two-colour immunofluorescent test increases the prevalence and litres of islet cell antibodies in Type 1 (insulin-dependent) diabetes meilitus. Diabetologia 1987; 30: 327–332
   PubMed Web of Science ®Google Scholar
• Grubin C., Daniels T., Tiovola B., Landin-Olsson M., Hagopian W., Li F., Karlsen A., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Schmidli R. S., Schmidli P. G.C., Bonifacio E., Participating L. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 1995; 44: 636–640
   PubMed Web of Science ®Google Scholar
• Arnqvist H., Littorin B., Nystrom L., Schersten B., Ostman J., Blohme G., Lithner F. Difficulties in classifying diabetes at presentation in the young adult. Diab. Med. 1993; 10: 606–613
   PubMed Web of Science ®Google Scholar
• Marshall M., Hoyer P., Petersen J., Hejnaes K., Genovese S., Dyrberg T., Bottazzo G. Contribution of glutamic decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J. Autoimmun. 1994; 7: 497–508
   PubMed Web of Science ®Google Scholar
• Lernmark Å., Klöppel G., Stenger D., Vathanaprida C., Fält K., Landin-Olsson M., Baskin D., Palmer J., Gown A., Petersen J., Li L., Edenvall H., Mauseth R. Heterogeneity of islet pathology in two infants with recent onset diabetes meilitus. Virchows Arch. 1995; 425: 631–640
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G.F., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Foulis A., McGill M., Farquharson M. Insulitis in type 1 (insulin-dependent) diabetes meilitus in manmacrophages, lymphocytes and interferon-gamma containing cells. J. Pathol. 1991; 165: 97–103
   PubMed Web of Science ®Google Scholar
• Rother E., Schochat T., Peter H. Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study. Rheumatol. Int. 1996; 15: 231–237
   PubMed Web of Science ®Google Scholar
• Svensson S., Sandier S., Sandier C. H. Lack of long-term beta-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the beta-cells to hyperglycaemia in vivo. J. Endocrinol. 1993; 136: 289–296
   PubMed Web of Science ®Google Scholar
• Martin S., Schernthaner G., Nerup J., Gries G. A., Koivisto V., Dupre J., Dtrandl E., Hamet P., McArthur R. G., Tan M. H., Dawson K., Metha A., Vanvliet S., van Graffenried B., Stiller C., Kolb H. and Group CRCT. Follow-up of cyclosporin. A treatment in type 1 (insulin dependent) diabetes meilitus: lack of long-term effects. Diabetologia 1991; 34: 429–434
   PubMed Web of Science ®Google Scholar
• Silverstein J., Maclaren N., Riley W., Spillar R., Radjenovic D., Johnson S. Immunosuppression with azathioprine and prednisolone in recent-onset insulin dependent diabetes meilitus. N. Engl. J. Med. 1988; 319: 599–604
   PubMed Web of Science ®Google Scholar
• Lampeter E. F., Tubes M., Klemens C., Brocker U., Friemann J., Kolb-Bachofen V., Gries F. A., Kolb H. Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass. Diabetologia 1995; 38: 1397–1404
   PubMed Web of Science ®Google Scholar